Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Management of moderate to severe plaque psoriasis with Kyntheum in daily practice

Next Previous
Trial Profile

Management of moderate to severe plaque psoriasis with Kyntheum in daily practice

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brodalumab (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms LIBERO
  • Sponsors LEO Pharma GmbH

Most Recent Events

  • 30 Jun 2025 Results assessing benefit of brodalumab 210 mg, an IL-17 receptor A antagonist, on patient-reported outcomes (PROs) in different psoriasis severity groups under real-world-evidence (RWE) conditions, published in the Journal of Dermatological Treatment.
  • 13 Oct 2023 According to a LEO Pharma media release, pooled analysis data of DELTA 1 & DELTA 2 will be presented at the 32nd European Academy of Dermatology and Venereology (EADV) Congress from the 11th to the 14th of October in Berlin, Germany.
  • 07 Sep 2020 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top